Skip to main content
. 2019 May 1;14(5):e0215952. doi: 10.1371/journal.pone.0215952

Fig 6. Experiment 3-Ladder.

Fig 6

After ICH, walking ability was impaired (all P<0.020). Glibenclamide did not impact walking ability in (A) the contralateral forelimb or (B) the contralateral hindlimb (all P>0.11). Sample size was n = 18/group. Data from uninjured limbs available in S1 Dataset.